ESPR:NASDAQ
Esperion Therapeutics Inc
$3.13
0.00%
(0.00) 1D
$3.13
arrow_downward
-0.04% (-0.0013)bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ESPR...
Open
$3.13
High
$3.14
Low
$3.13
Mkt. cap
805.76M
Avg. vol.
17.58M
Volume
8.41M
52-wk high
$4.18
52-wk low
$0.95
EPS
-$0.06
Beta
1.07
Shares outstanding
257.43M
No. of employees
294
Open
$3.13
High
$3.14
Low
$3.13
Mkt. cap
805.76M
Avg. vol.
17.58M
Volume
8.41M
52-wk high
$4.18
52-wk low
$0.95
EPS
-$0.06
Beta
1.07
Shares outstanding
257.43M
No. of employees
294
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to ESPR in the past 3 months
Hold
Buy
0
Hold
5
Sell
1
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ESPR in the last 3 months.
Highest
Current $3.13
$3.28 (+4.79%)
Average
$2.91 (-7.03%)
Lowest
$1.78 (-43.13%)
News stories
From sources across the web
Simply Wall Street
·
10 minutes ago
SoFi Class Action Puts Reporting Practices And Valuation Premium In Focus
Fortune
·
1 hour ago
SpaceX and other mega IPOs may wait years to join the S&P 500
Profile
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
About Esperion Therapeutics Inc
CEOSheldon Koenig
Employees294
FoundedMay 1998
Headquarters-
SectorPharmaceutical industry
Websiteesperion.com
AI content may include mistakes. Learn more